GSK3B and hepatocellular carcinoma: Consequently, numerous active metabolites of TCM can impede the Wnt/β-catenin signalling pathway by enhancing the breakdown of β-catenin through the inhibition of GSK-3β phosphorylation or by augmenting its activity, thereby demonstrating an anti-HCC action.